Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: The M77001 Study Group. - Marty,M.; Cognetti,F.; Maraninchi,D. (J Clin Oncol, 2005)